Skip to content

Effect of HEPA Air Filters on Subclinical Markers of Cardiovascular Health

Assessing the Impact of Wood Stove Interventions on Air Quality

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01256957
Acronym
WEST
Enrollment
56
Registered
2010-12-09
Start date
2008-11-30
Completion date
2009-04-30
Last updated
2016-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endothelial Function, Oxidative Stress, Systemic Inflammation

Brief summary

The purpose of this study is to evaluate the ability of portable high efficiency particle air (HEPA) filters to reduce exposures to PM2.5 and woodsmoke air pollution indoors and to improve subclinical indicators of microvascular function, systemic inflammation, and oxidative stress among healthy adult participants.

Detailed description

The investigators will use portable HEPA filters in a single-blind randomized crossover design. Each participant's home will be monitored for two consecutive seven-day periods, during which time two HEPA units (one in the bedroom and one in the main living room) will be operated indoors. During one 7-day period the HEPA filters will be operated normally, and during the other period the HEPA unit will be operated without the internal filter in place (i.e., placebo filtration), thus blinding participants to the filters' status. The order of filtration or non-filtration will be random. At the end of each 7-day period microvascular function will be assessed, blood will be collected for assessment of systemic inflammatory markers, and urine will be collected for assessment of oxidative stress markers.

Interventions

Sponsors

University of British Columbia
CollaboratorOTHER
Health Canada
CollaboratorOTHER_GOV
Ministry of Environment, British Columbia
CollaboratorOTHER
Simon Fraser University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 19 years or older * Non-smoking household * Lives in study region (Smithers or Telkwa British Columbia)

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Reactive hyperemia indexAfter 1 week of air filtration

Secondary

MeasureTime frame
C-reactive proteinAfter 1 week of filtration

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026